mynth
← DATABASE
06/2016

ACTEON acquired by BRIDGEPOINT, RAISE & FLEXSTONE PARTNERS

FRANCE Life Sciences / Medical Devices REV €100–200M

Context

The third LBO of Acteon marks a definitive strategic shift toward institutional global leadership, orchestrated by Bridgepoint Development Capital alongside Raise Investissement and Euro Private Equity. The strategic rationale for this transaction centers on an "innovation-acceleration" play, merging the group’s industry-leading technical operational depth in ultrasonics with the sponsor’s extensive international commercial infrastructure. This structural alignment provides the organization with the scientific talent and logistical hardware required to address the increasing complexity of the global digital dentistry market. This operation allows the group to execute a definitive structural expansion of its product suite, particularly through a renewed emphasis on research and development following several years of stabilization. By incorporating the sponsor’s strategic discipline, the group is now positioned to leverage its recognized leadership in high-frequency imaging to deepen its presence in high-stakes markets such as North America and Asia.

It is worth noting that the fund Edmond De Rothschild Capital Partners took control of Acteon through an LBO in 2006.

ACTEON, which reported an EBITDA margin of [members only] in 2015, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Acteon is a France company specialized in Dental Technology. The organization has built its name as a high-fidelity provider of specialized medical devices, particularly leading the field in ultrasound surgery and digital medical imaging. Instead of producing generic dental tools, they thrive on a philosophy of clinical precision, offering innovative hardware that enables dentists and surgeons to perform minimally invasive procedures with superior imaging clarity. Their growth is currently fueled by a rigorous focus on new product development, a shift that has allowed them to break out of historical stagnation and capture significant market share in fast-growing dental tech segments.

Ent. Value

€100–200M

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2015
€100–200M
€5–25M
[members only]
2014
€100–200M
€5–25M
[members only]

Other operations with ACTEON

Other operations with ACTEON

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
08/2018DENTRESSANGLEACTEONFRANCEMedical Devices
01/2006EDMOND DE ROTHSCHILD CAPITAL PARTNERSACTEONFRANCEMedical Devices

REFERENCES

Revenue range: €100–200M

EBITDA range: €5–25M

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ACTEON by BRIDGEPOINT / RAISE / FLEXSTONE PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: bridgepoint / flexstone partners / raise